United Kingdom· GB-APID-22649711000001108
Idarubicin 5mg powder for solution for injection vials
A idarubicin product containing idarubicin, registered in United Kingdom by Teva UK Ltd. The same ATC class is registered in 17 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Idarubicin is registered in 17 of 19 countries.
Countries holding a registration under ATC L01DB06 (idarubicin), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 10 of them publish a price we can compare per daily dose
Idarubicin · ATC L01DB06
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Idarubicin
- Manufacturer
- Teva UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- L01DB06
- ATC class
- Idarubicin
- Defined daily dose
- 6 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
435 interactions on record for idarubicin.
Graded by severity as the source publishes them — 98 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Idarubicin · interactions on record
435 records
- 98 severe
- 328 moderate
- 9 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- QuinidineC01BA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Idarubicin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumZavedos 5 mgPfizer
- CzechiaZAVEDOSPfizer, spol. s r.o., Praha
- NorwayZavedosPfizer AS
- PolandZavedosPfizer Europe MA EEIG
- FinlandIdarubicin AccordAccord Healthcare B.V.
- United StatesIdamycin PFSPfizer Laboratories Div Pfizer Inc
- FranceIDARUBICINE ACCORD 10 mg/10 ml, solution pour perfusionACCORD HEALTHCARE FRANCE
- SpainIDARUBICINA ACCORD 1 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFGAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Idarubicin Ebewe, Idarubicin Hexal
- Belgium · Zavedos
- Bulgaria · Заведос
- Cyprus · Zavedos
- Czechia · Zavedos
- Germany · Idarubicin Hexal, Idarubicin Hikma
- Denmark · Zavedos
- Spain · Idarubicina Sandoz, Zavedos
- Finland · Idarubicin Accord, Zavedos
- France · Idarubicine Accord, Zavedos
- Greece · Zacorist, Zavedos
- Croatia · Zavedos
- Hungary · Zavedos
- Ireland · Zavedos
- Iceland · Zavedos
- Italy · Zavedos
- Lithuania · Zavedos
- Luxembourg · Zavedos
- Latvia · Zavedos
- Netherlands · Zavedos
- Norway · Zavedos
- Poland · Idarubicin Accord, Zavedos
- Portugal · Idarrubicina Accord, Idarrubicina Azevedos
- Romania · Zavedos
- Sweden · Zavedos
- Slovenia · Zavedos
- Slovakia · Zavedos
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b5710d7e-43d0-44ee-9afa-a835c37edb49 GET /v1/drugs/b5710d7e-43d0-44ee-9afa-a835c37edb49?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "22649711000001108",
"desc": "Idarubicin 5mg powder for solution for injection vials (Teva UK Ltd)",
"form": "Powder for solution for injection",
"vpid": "41788911000001104",
"source": "dmd",
"vtm_id": "776298002",
"strength": "5 mg",
"substance": "Idarubicin",
"ingredient": "Idarubicin hydrochloride",
"supplier_code": "3849901000001105"
}See everything about idarubicin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.